Your browser doesn't support javascript.
loading
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial.
Corren, Jonathan; Larson, David; Altman, Matthew C; Segnitz, R Max; Avila, Pedro C; Greenberger, Paul A; Baroody, Fuad; Moss, Mark H; Nelson, Harold; Burbank, Allison J; Hernandez, Michelle L; Peden, David; Saini, Sarbjit; Tilles, Stephen; Hussain, Iftikhar; Whitehouse, Don; Qin, Tielin; Villarreal, Miguel; Sever, Michelle; Wheatley, Lisa M; Nepom, Gerald T; Sanda, Srinath.
Afiliación
  • Corren J; Departments of Medicine and Pediatrics, David Geffen School of Medicine, University of California, Los Angeles. Electronic address: jcorren@ucla.edu.
  • Larson D; Immune Tolerance Network, Bethesda.
  • Altman MC; Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle; Benaroya Research Institute, Seattle.
  • Segnitz RM; Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle.
  • Avila PC; Division of Allergy-Immunology, Feinberg School of Medicine, Chicago.
  • Greenberger PA; Division of Allergy-Immunology, Feinberg School of Medicine, Chicago.
  • Baroody F; University of Chicago Medicine and Comer Children's Hospital, Chicago.
  • Moss MH; Section of Allergy, Pulmonary and Critical Care, University of Wisconsin Hospital and Clinics, Madison.
  • Nelson H; Department of Medicine, Division of Allergy and Clinical Immunology, National Jewish Health, Denver.
  • Burbank AJ; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill.
  • Hernandez ML; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill.
  • Peden D; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill.
  • Saini S; Division of Allergy & Clinical Immunology, Johns Hopkins University, Baltimore.
  • Tilles S; ASTHMA Inc, Clinical Research Center, Seattle.
  • Hussain I; Vital Prospects Clinical Research Institute, Tulsa.
  • Whitehouse D; Immune Tolerance Network, San Francisco.
  • Qin T; Immune Tolerance Network, Bethesda.
  • Villarreal M; Rho Federal Systems Division, Durham.
  • Sever M; Rho Federal Systems Division, Durham.
  • Wheatley LM; National Institutes of Health, Bethesda.
  • Nepom GT; Immune Tolerance Network, Seattle.
  • Sanda S; Immune Tolerance Network, San Francisco.
J Allergy Clin Immunol ; 151(1): 192-201, 2023 01.
Article en En | MEDLINE | ID: mdl-36223848
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Alérgenos / Rinitis Alérgica Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Alérgenos / Rinitis Alérgica Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2023 Tipo del documento: Article